Skip to main content
. Author manuscript; available in PMC: 2020 Jul 6.
Published in final edited form as: Drug Alcohol Depend. 2019 Feb 27;198:21–27. doi: 10.1016/j.drugalcdep.2019.01.026

Table 3.

Unadjusted bivariate associations with illicit drug use in the past 90 days as an outcome among young adult cannabis users in Los Angeles (n = 366).

Variable Illicit No illicit Unadjusted OR 95%CI
drug use n = 115 n(%) drug use n = 251 n(%)
Demographics
Non-Hispanic White 45(39.8) 47(19.0) 2.8(1.7–4.6)***
Age, mean (SD) 21.2(2.6) 21.2(2.4) 1.0(0.9–1.1)
Heterosexual 90(80.4) 199(81.9) 0.9(0.5–1.6)
Female 35(30.4) 89(35.5) 0.8(0.5–1.3)
Cannabis forms
Bud/flower 115(100.0) 247(98.4) -
Edibles 76(66.1) 140(55.8) 1.6(1.0–2.5)
Concentrates (wax, shatter, dab, oil) 87(75.7) 128(51.0) 3.0(1.8–4.9)***
Other cannabis practices
Medical Cannabis Patient 72(62.6) 138(55.0) 1.4(0.9–2.2)
Self-reported medical cannabis use 61(53.0) 162(64.5) 0.6(0.4–1.0)*
Typically used cannabis alone 28(24.3) 78(31.1) 0.7(0.4–1.2)
Days of cannabis use, mean(SD) 75.2(20.8) 66.3(28.5) 1.01(1.01–1.02)**
Ever substituted cannabis for illicit drugs 15(13.0) 14(5.6) 2.5(1.2–5.5)*
Mental health indicators
Ever been prescribed tranquilizers 16(13.9) 32(12.7) 1.1(0.6–2.1)
Ever been prescribed antidepressants 20(17.4) 46(18.3) 0.9(0.5–1.7)
Used cannabis to relieve feeling uptight and anxious 76(66.1) 154(61.4) 1.2(0.8–2.0)
Used cannabis to cope with feeling depressed 51(44.3) 100(39.8) 1.2(0.8–1.9)
SDS, mean(SD) 2.8(3.0) 2.3(2.5) 1.1(1.0–1.2)

Note.

p < 0.1,

*

p < 0.05,

**

p < 0.01,

***

p < 0.001.